Emergent BioSolutions
EBS
#6766
Rank
HK$4.94 B
Marketcap
HK$92.64
Share price
-1.24%
Change (1 day)
30.10%
Change (1 year)

Emergent BioSolutions (EBS) - Total assets

Total assets on the balance sheet as of September 2025 : HK$11.37 Billion

According to Emergent BioSolutions 's latest financial reports the company's total assets are HK$11.37 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Emergent BioSolutions - Total assets on balance sheet (from 2004 to 2025)

Total assets by year

Year Total assets Change
2024-12-31HK$10.78 B-24.23%
2023-12-31HK$14.23 B-42.44%
2022-12-31HK$24.73 B7.27%
2021-12-31HK$23.06 B3.18%
2020-12-31HK$22.35 B23.31%
2019-12-31HK$18.12 B3.82%
2018-12-31HK$17.45 B108.79%
2017-12-31HK$8.36 B11.15%
2016-12-31HK$7.52 B-6.45%
2015-12-31HK$8.04 B10.44%
2014-12-31HK$7.28 B49.84%
2013-12-31HK$4.85 B11.1%
2012-12-31HK$4.37 B2.97%
2011-12-31HK$4.24 B9.09%
2010-12-31HK$3.89 B45.68%
2009-12-31HK$2.67 B18.94%
2008-12-31HK$2.24 B5.37%
2007-12-31HK$2.13 B15.08%
2006-12-31HK$1.85 B138.21%
2005-12-31HK$0.77 B44.96%
2004-12-31HK$0.53 B
2002-12-31HK$0.17 B-10.35%
2001-12-31HK$0.19 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Merck
MRK
HK$1.008 T 8,766.94%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
HK$1.80 B-84.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$641.92 B 5,544.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
HK$5.04 B-55.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$1.624 T 14,186.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$310.26 B 2,627.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
HK$87.91 M-99.23%๐Ÿ‡บ๐Ÿ‡ธ USA